Changes on recovery in the concentrations of tryptophan and the biogenic amine metabolites in the cerebrospinal fluid of patients with affective illness.
D000328:Adult; D000342:Affective Symptoms / Q000134:cerebrospinal fluid* / Q000188:drug therapy; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001679:Biogenic Amines / Q000134:cerebrospinal fluid*; D001714:Bipolar Disorder / Q000134:cerebrospinal fluid; D002090:Butyrophenones / Q000627:therapeutic use; D003863:Depression / Q000134:cerebrospinal fluid; D005260:Female; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D008297:Male; D008875:Middle Aged; D010640:Phenothiazines; D011955:Receptors, Drug; D012701:Serotonin / Q000134:cerebrospinal fluid; D014364:Tryptophan / Q000134:cerebrospinal fluid*
D014150:Antipsychotic Agents; D001679:Biogenic Amines; D002090:Butyrophenones; D010640:Phenothiazines; D011955:Receptors, Drug; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D014364:Tryptophan; D006719:Homovanillic Acid